Toxicity and response criteria of the Eastern Cooperative Oncology Group - Wikidata - wikimedia - TriplyDB

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Toxicity and response criteria of the Eastern Cooperative Oncology Group

http://www.wikidata.org/entity/Q29619399

about

The characteristics of patients who discontinue their dying process - an observational study at a single university hospital centre Parenteral anticoagulation in ambulatory patients with cancer Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma Maintenance therapy for advanced non-small cell lung cancer (NSCLC)Erlotinib for advanced pancreatic cancer Second-line, post-docetaxel therapy for advanced, androgen deprivation-refractory prostate cancer Herbal medicines for advanced colorectal cancer Awake language mapping for cerebral glioma surgery Herbal medicines for advanced colorectal cancer Image guided surgery for the resection of brain tumours Intra-operative imaging for neuro-oncology Second-line, post-docetaxel therapy for advanced, androgen deprivation-refractory prostate cancer Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Chemotherapy wafers for high grade glioma Cardioprotective interventions for cancer patients receiving anthracyclines Cardioprotective interventions for cancer patients receiving anthracyclines Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastases Incentives and disincentives to participation by clinicians in randomised controlled trials Selenium for the side effects of chemotherapy, radiotherapy and surgery in cancer patients Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib Combination anastrozole and fulvestrant in metastatic breast cancer Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial Safety, activity, and immune correlates of anti-PD-1 antibody in cancer Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program Phase I clinical study of a novel lipophilic platinum complex (SM-11355) in patients with hepatocellular carcinoma refractory to cisplatin/lipiodol Experiencing neutropenia: quality of life interviews with adult cancer patients.Moving beyond Karnofsky and ECOG Performance Status Assessments with New Technologies Development and novel therapeutics in hepatocellular carcinoma: a review Missing data in randomized controlled trials testing palliative interventions pose a significant risk of bias and loss of power: a systematic review and meta-analyses Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis.Systematic review on quality of life outcomes after gastrectomy for gastric carcinoma The treatment landscape in thyroid cancer: a focus on cabozantinib The level of association between functional performance status measures and patient-reported outcomes in cancer patients: a systematic review Nutritional risk assessment in critically ill cancer patients: systematic review Molecular marker for predicting treatment response in advanced renal cell carcinoma: does the promise fulfill clinical need?Bringing Patient-Centered Care to the Fore in Diseases of the Pancreas Clinical and laboratory prognostic indicators in chronic lymphocytic leukemia

P2860

Q21999586-83A3F617-7FC8-4A9F-8829-354A9B32C76C Q22252972-160067DA-F0CC-451C-9156-4204F5A5BC64 Q24186554-6CDE88A5-3726-4918-8DFF-1EA22A6C3FD7 Q24186668-047DE3DE-2D12-4FCA-942D-9FA5A0FFAE63 Q24186793-91A2D4AB-26B0-4A9E-A9AB-D83A31662104 Q24186983-1B93F282-0C5F-4044-88EF-7C8D32F3DA78 Q24192969-99440CA4-9A91-44D8-ABCA-89ED4FF95A23 Q24197971-E1A34BD7-367F-48C4-B2E3-0E26BC7F8C62 Q24200795-B9B1A958-637D-46EC-84AC-EFC051783BD7 Q24200914-2040959C-77A8-49F8-B953-B073E2275D4F Q24200959-1F46B78F-2C3C-42AC-9D3E-1AC982CFB9AB Q24201395-5BB7661E-C3EB-45A7-A842-E5FDFA41CF67 Q24201772-0135F42A-8BEE-4E7B-8A01-742A4915941F Q24234857-16D88F51-72E3-419F-8D68-1BB944F58CB0 Q24235112-02C4EDE4-C408-449D-ABD5-EEAA54499D12 Q24235641-36929984-3DA1-4DF8-8298-E73B2145362F Q24236338-7A6DE150-AA50-416E-8AEF-96F4B4B375F1 Q24243021-AB73AF95-317F-4C30-8418-7B3CE254286F Q24245008-146DC199-5293-4EEC-9D54-E728E79F6BA8 Q24245168-12740908-7314-4B6C-8970-AD59568406A4 Q24245558-64AD706D-F15A-4FFE-98DD-807A771BDFFB Q24246425-B9AE35D0-BD93-4421-9E40-D89063EC2A0B Q24594790-D926E5B0-E77C-4087-A4C9-94B38569E3E3 Q24595386-05CDC249-BE70-447B-ABBB-5B943168D3C7 Q24628047-0CED0259-2B3E-4BCC-A6C2-CEF0E4738C38 Q24633070-707CC4D9-E7A9-418A-8ABD-301658C26540 Q24642481-BEDA4CBD-59CC-4CDC-9BA8-DB7A86A29CB7 Q24651008-A9EF64AC-4A36-466F-8981-904818278033 Q24814995-BC397084-6D16-43DF-B504-D54565C802AB Q26749492-18F07DE1-4179-4B2F-960E-84BFC7EF51F3 Q26752854-0BEA86E9-EF37-4B56-A237-51D2BE259E2C Q26771540-10D61A86-614B-4322-8EEE-964D43BE0F60 Q26780309-BD90731B-97C8-4A2E-9A7D-E1578A8709C5 Q26781040-A976E7F3-9697-4B5E-9AA3-C572989E9E74 Q26796404-80B22CAF-FC92-4A8A-B6F7-D9A70C21EB08 Q26796534-41645824-443B-4A7B-8A9C-84E706F06856 Q26798173-C6767B9C-9FF2-4B4C-ADFF-D499BB6A6BA3 Q26825512-311C9FFE-4010-4723-A853-CD21C7EE0CB8 Q26830174-4FA30425-DBCC-4EC2-BE55-314F74872EA5 Q26830323-CAECD164-FBA0-4156-96E9-8261592058A8

P2860

Toxicity and response criteria of the Eastern Cooperative Oncology Group

http://www.wikidata.org/entity/Q29619399

description

1982 nî lūn-bûn

@nan

1982 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1982 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1982年の論文

@ja

1982年論文

@yue

1982年論文

@zh-hant

1982年論文

@zh-hk

1982年論文

@zh-mo

1982年論文

@zh-tw

1982年论文

@wuu

name

Toxicity and response criteria of the Eastern Cooperative Oncology Group

@ast

Toxicity and response criteria of the Eastern Cooperative Oncology Group

@en

type

label

Toxicity and response criteria of the Eastern Cooperative Oncology Group

@ast

Toxicity and response criteria of the Eastern Cooperative Oncology Group

@en

prefLabel

Toxicity and response criteria of the Eastern Cooperative Oncology Group

@ast

Toxicity and response criteria of the Eastern Cooperative Oncology Group

@en

P1433

Q29619399-8A9A2A13-B6AE-4D18-AD71-E3389A680729

P1476

Q29619399-0448A91C-765E-4149-9744-FFE2C5DF238D

P2093

Q29619399-0723B335-0928-4989-A208-215D0ECBB58A

Q29619399-12B5515E-8E02-4DF6-BA80-279EB8C27066

Q29619399-45BCA64E-6A65-47FD-98B2-4B6DDC550A59

Q29619399-4F922FAD-9463-4CBC-8432-1AB498F3B8E7

Q29619399-B50F82F4-AEE7-428D-A1BC-FE060643E083

Q29619399-CD239E65-BB06-4324-9810-0DB8DBC6C89B

Q29619399-F51EB227-77BD-41A0-B076-5038B085A9B6

P304

Q29619399-3BAF1153-EF83-4FB0-97A9-A10D8EB81609

P31

Q29619399-3E31149B-F84F-4BA5-8544-9E002977EA69

P3181

Q29619399-05BAC550-7CB2-4DFC-8097-A4AD148A7F89

Q29619399-9AD5F38C-8B36-466D-AD45-8ABDD92BA540

P356

Q29619399-82C95BEE-43A2-4D9A-A462-718EF36FC5AF

P407

Q29619399-C2811B26-0F8E-4679-87E6-0DBF0B9CB2D4

P433

Q29619399-A3BF651A-ED82-43DD-8A74-9FB0CBCEBC24

P478

Q29619399-6D6FFC24-5AD7-4EFD-8689-B583406D02BC

P577

Q29619399-916658D5-A51D-4E04-852A-D917716EAC9E

P698

Q29619399-C64DA2E2-0A2D-40FC-AA35-4CA722CE0922

P3181

P356

00000421-198212000-00014

P1433

American Journal of Clinical Oncology

P1476

Toxicity and response criteria of the Eastern Cooperative Oncology Group

@en

P2093

Carbone PP

http://www.w3.org/2001/XMLSchema#string

Creech RH

http://www.w3.org/2001/XMLSchema#string

Davis TE

http://www.w3.org/2001/XMLSchema#string

Horton J

http://www.w3.org/2001/XMLSchema#string

McFadden ET

http://www.w3.org/2001/XMLSchema#string

Oken MM

http://www.w3.org/2001/XMLSchema#string

Tormey DC

http://www.w3.org/2001/XMLSchema#string

P304

649-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

187321

http://www.w3.org/2001/XMLSchema#string

210385

http://www.w3.org/2001/XMLSchema#string

P356

10.1097/00000421-198212000-00014

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

1982-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7165009

http://www.w3.org/2001/XMLSchema#string